West Virginia University Cancer Institute's Clinical Research Unit (CRU) is dedicated to providing the services and expertise that investigators need to conduct clinical trials and expand the growing body of biomedical knowledge. We offer a wide range of administrative and budgetary services to both clinical investigators and private industry. Because West Virginia University is the state's primary research institution, the CRU physicians represent a comprehensive range of specializations. Our staff has a sterling reputation for excellent patient care as well as timely delivery of valid and reliable data. Unlike many other academic health centers, West Virginia University provides primary care services to a large, stable population of rural patients. WVU also provides secondary and tertiary care. Our patient population ensures a high degree of follow-up care and study completion that many other clinical trials facilities cannot offer. Clinical trials are conducted at the West Virginia University Cancer Institute and the Robert C. Byrd Health Sciences Center (HSC) at West Virginia University in Morgantown.
The WVU Cancer Institute is enrolling patients in an innovative clinical trial to treat uterine and vaginal cancer.
Patrick Ma, M.D., co-leader of the WVU Cancer Institute Sara Crile Allen & James Frederick Allen Comprehensive Lung Cancer Program and director of the Clinical Lung Cancer Program, and Xiaoliang Wu, M.D., Ph.D., postdoctoral research fellow in Dr. Ma’s lab, were featured presenters at the 2018 American Society of Clinical Oncology (ASCO) Annual Scientific Meeting this June.
The WVU Cancer Institute Employee Recognition Awards Committee is now accepting nominations for its annual Employee Recognition Awards Program.